Abstract:Objective: To evaluate the efficacy and safety of internal XEN gel stent implantation or combined with phacoemusification and intraocular lens (IOL) implantation in the treatment of glaucoma. Methods: It was a retrospective case series study. Forty-five patients (28 males and 17 females; 52 eyes) who had different types of glaucoma treated at the Shenzhen Eye Hospital from December 2021 to June 2023 were included. XEN gel stent implantation (the XEN group) or XEN implantation combined with phacoemusification and IOL implantation (the combined group) were performed in these patients. The postoperative follow-up was 18 months. The observational indexes included the best corrected visual acuity (recorded as the logarithm of the minimum angle of resolution), intraocular pressure (IOP), XEN implantation quadrant, number of IOP-lowering medications, corneal endothelial cell count, operation success rate and surgical complications. The one-way repeated measures of variance, LSD-t test, and rank sum test were used for statistical analysis. Results: There were 28 patients (33 eyes) in the XEN group and 17 patients (19 eyes) in the combined group. The postoperative best corrected visual acuity had no significant change in the XEN group, but improved significantly (0.21±0.30 at 6 months; P<0.05) in the combined group, compared with the preoperative value. The IOP of the two groups at 18 months after surgery [(12.2±3.1) and (11.9±3.9) mmHg (1 mmHg=0.133 kPa)] was significantly lower than that before surgery [(22.1±8.5) and (19.4±10.2) mmHg; P<0.05]. The average number of IOP-lowering medications in all patients was 3 (2, 3) before surgery and 0 (0, 0) at 18 months after surgery. The difference was statistically significant (P<0.05). In the XEN group, the corneal endothelial cell count was (2 387.37±478.22) cells/mm² preoperatively and (2 193.89±311.96) cells/mm² at 12 months. The decrease showed no statistical significance. The XEN gel stent was implanted in the supranasal quadrant in 8 eyes (15.4%), in the inferonasal quadrant in 36 eyes (69.2%), and in the infratemporal quadrant in 8 eyes (15.4%). The operation success rate [complete success rate, 86.5% (45/52); conditional success rate, 9.6% (5/52)] was 96.2% (50/52). The filtering bleb scarring occurred in 9.6% (5/52) of eyes. A small amount of hyphema, postoperative shallow anterior chamber, transient hypertension, and intraoperative drain breakage were found in 7.7% (4/52) of eyes, respectively. A small amount of subconjunctival bleeding was observed in 5.8%(3/52) of eyes. Re-implantation of an XEN gel stent was performed in 5.8% (3/52) of eyes. The intraoperative conjunctival tissue rupture, hypotony macular edema, and drain exposure were observed in 1.9% (1/52) of eyes, respectively. Conclusion: The XEN gel stent implantation or combined with phacoemusification and IOL implantation was effective and safe in treating different types of glaucoma, but its long-term clinical efficacy needs further follow-up observations in multi-center, larger-scale research.

Clinical observations of gold ring implantation through anterior chamber angle for the treatment of refractory glaucoma

Gold Ring Implantation Through Anterior Chamber Angle for Glaucoma in a Rabbit Model

A Preliminary Study on Modified Gold Ring Implantation Through Anterior Chamber Angle in Rabbit

Clinical study on the management of refractory glaucoma by Ex-press filtration device implantation

Clinical study on the management of angle-closure glaucoma by phacoemulsification with foldable posterior chamber intraocular lens implantation.

Efficacy and Safety of Combined Phacoemulsification, Intraocular Lens Implantation, Goniosynechialysis, and Trabectome in Patients With Primary Angle-Closure Glaucoma

Observation on Changes of Anterior Chamber and Chamber Angle Structures after Posterior Chamber Phakic Intraocular Lens Implantation by Ultrasound Biomicroscopy

The primary efficacy of trabeculectomy with immersion of mitomycin C and amniotic membrane implantation for refractory glaucoma

[Clinical effect of XEN gel stent implantation or combined with phacoemusification and intraocular lens implantation on glaucoma]

Efficacy and safety of phacoemulsification plus goniosynechialysis and trabectome in patients with primary angle-closure glaucoma

Safety and efficacy of XEN gel drainage tube implantation in the treatment of refractory glaucoma

Comparison of peripheral iridotomy with the phacoemulsification and intraocular lens implantation in treating primary angle-closure glaucoma.

Effect of Intraocular Lens Biomaterials on the Treatment of Primary Angle Closure Glaucoma

Management of Acute Angle-Closure Glaucoma by Phacoemulsification Combined with Goniosynechialysis

Clinical application analysis of phacoemulsification in acute angle-closure glaucoma with cataract

The Effect of Phacoemulsification with Foldable Posterior Chamber Intraocular Lens Implantation in the Management of Angle-Closure Glaucoma with Cataract

Imaging of anterior chamber in eyes with primary angle-closure glaucoma before and after IOL implantation with phacoemulsification

Clinical study of incision at pars plana of ciliary on refractory glaucoma filtering surgery

Clinical effects of phacoemulsification on primary angle-closure glaucoma at different stages

Phacoemulsification with the Implantation of Posterior Chamber Foldable Intraocular Lens in Glaucomatous Eyes after Filtering Surgery

Clinical Research of the Implantation of Phakic Anterior Chamber Intraocular Lens for High Myopia